Avidity Biosciences Dividend
Dividend criteria checks 0/6
Avidity Biosciences does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$2.22 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Here's Why We're Not Too Worried About Avidity Biosciences' (NASDAQ:RNA) Cash Burn Situation
Mar 01Avidity Biosciences: DMD Advancement And 2024 Catalysts Make It A Must-Watch
Feb 29Is Avidity Biosciences (NASDAQ:RNA) In A Good Position To Deliver On Growth Plans?
Nov 04Here's Why We're Not Too Worried About Avidity Biosciences' (NASDAQ:RNA) Cash Burn Situation
Apr 08Here's Why We're Not Too Worried About Avidity Biosciences' (NASDAQ:RNA) Cash Burn Situation
Nov 17Avidity slips 20% as FDA places lead asset on partial clinical hold
Sep 27We Think Avidity Biosciences (NASDAQ:RNA) Can Afford To Drive Business Growth
Jul 29Avidity stock rises amid Chardan starting coverage with Buy
Jul 20Avidity, Dyn gain as Raymond James turns bullish on targeted oligonucleotides
Jul 12We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely
Mar 26Avidity Biosciences: Risks And Potential
Dec 09We Think Avidity Biosciences (NASDAQ:RNA) Can Afford To Drive Business Growth
Nov 30Avidity Biosciences (NASDAQ:RNA) Is In A Good Position To Deliver On Growth Plans
Jun 07Companies Like Avidity Biosciences (NASDAQ:RNA) Are In A Position To Invest In Growth
Feb 22Avidity Biosciences Has A Promising RNA Therapy Platform
Jan 13Avidity inks research deal with Bristol Myers' subsidiary, gives 2021 pipeline updates
Jan 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RNA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RNA's dividend payments have been increasing.
Dividend Yield vs Market
Avidity Biosciences Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (RNA) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (RNA) | 0% |
Notable Dividend: Unable to evaluate RNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate RNA's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RNA has not reported any payouts.